Asian Spectator

The Times Real Estate

.

QBiotics receives first registration for tigilanol tiglate wit...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
BRISBANE, Australia, Jan. 20, 2020 /PRNewswire-AsiaNet/ -- - STELFONTA(R) (tigilanol tiglate) approved by the European Medicines Agency (EMA), making it the first pharmaceutical treatment available for all grades of canine non-metastatic mast cell tumours (MCT)[1] - The approval marks the first registra...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Expert Legal Help | Personal Injury Lawyer in Brisbane

Suffering a personal injury can be a traumatic and life-changing experience, leaving you wondering what to do next. Navigating the complex world of personal injury law in Brisbane can be overwhelmin...

#IndonesiaGelap: Alarm bagi publik agar tak terlena narasi penguasa

Mahasiswa dari berbagai kampus berpartisipasi dalam aksi Indonesia Gelap di Jakarta untuk memprotes kebijakan pemerintah.@jackjackparrrBermula dari media sosial, tagar #IndonesiaGelap menjadi bentuk a...

Ketika pemberitaan penuh tekanan, bagaimana cara tetap ‘update’ tanpa ‘doomscrolling’?

Mart Production/PexelsAwalnya sesederhana kita mengintip media sosial favorit di tengah malam sebelum tidur. Lalu muncullah judul-judul berita yang menarik perhatian dengan keterangan “breaking ...